CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net earnings (loss)	$ (6,677)	$ 3,294	$ 2,699
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
Depreciation and amortization	1,275	1,241	1,293
Stock compensation expense	204	212	216
Impairment	7,311	13	529
(Gain) on debt extinguishment	(1)	0	0
Deferred income taxes	(60)	13	(78)
(Gain) loss on divestitures, net	(2)	(120)	(152)
Changes in assets and liabilities
Premium and trade receivables	1,480	(4,333)	(2,380)
Other assets	(230)	46	5
Medical claims liabilities	2,336	368	1,261
Unearned revenue	80	(54)	238
Accounts payable and accrued expenses	(657)	(528)	3,398
Other long-term liabilities	(46)	(70)	856
Other operating activities, net	75	72	168
Net cash provided by operating activities	5,088	154	8,053
Cash flows from investing activities:
Capital expenditures	(767)	(644)	(799)
Purchases of investments	(4,541)	(7,183)	(6,622)
Sales and maturities of investments	5,780	5,785	5,523
Divestiture proceeds, net of divested cash	0	990	707
Net cash provided by (used in) investing activities	472	(1,052)	(1,191)
Cash flows from financing activities:
Proceeds from long-term debt	750	1,300	2,335
Payments and repurchases of long-term debt	(1,895)	(622)	(2,316)
Common stock repurchases	(475)	(3,124)	(1,633)
Proceeds from common stock issuances	37	46	44
Purchase of noncontrolling interest	(19)	0	(88)
Other financing activities, net	(19)	(6)	0
Net cash used in financing activities	(1,621)	(2,406)	(1,658)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	8	(32)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents	3,939	(3,296)	5,172
Cash and cash equivalents reclassified (to) from held for sale	(138)	0	(50)
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period	14,156	17,452	12,330
Cash, cash equivalents and restricted cash and cash equivalents, end of period	17,957	14,156	17,452
Supplemental disclosures of cash flow information:
Interest paid	647	688	688
Income taxes paid, net	448	1,002	887
The following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:
Cash and cash equivalents	17,888	14,063	17,193
Restricted cash and cash equivalents, included in restricted deposits	69	93	259
Total cash, cash equivalents, and restricted cash and cash equivalents	$ 17,957	$ 14,156	$ 17,452